Streetbeat News

Regulatory

ACST

Acasti Pharma has announced its alignment with the FDA on the GTX-104 Pivotal Phase 3 Safety Trial Protocol and confirmed the planned initiation of STRIVE-ON in aSAH patients in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 1:03 pm

DWAC

Truth Social's merger partner has reached an $18M settlement with the SEC. The news may have implications for Digital World Acquisition Corp. (DWAC), which is associated with Truth Social.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 1:03 pm

DWAC

Digital World Acquisition Corp (DWAC), the financial firm linked to Donald Trump’s Truth Social platform, has reached an $18m settlement with the Securities and Exchange Commission (SEC) to end the investigation into its merger with the company. The settlement allows DWAC to proceed with the merger, turning Truth Social into a public company. This news follows the indictment of three individuals involved in the merger for insider trading.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 1:02 pm

SPY

USO

Iran attempted to seize two oil tankers near the Strait of Hormuz, firing shots at one of them, according to the U.S. Navy. The Iranian naval vessels retreated after the U.S. Navy responded to distress signals. Iran has reportedly seized at least five commercial vessels in the last two years, many of which occurred near the Strait of Hormuz, a critical route for crude oil transportation. This incident escalates U.S.-Iranian tensions, which have been rising since the U.S. withdrew from Iran's 2015 nuclear agreement and reinstated sanctions.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 12:58 pm

SPY

The USA Redbook Year-over-Year (YoY) has increased to 0.7% from the previous 0.5%.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 12:57 pm

PALI

Palisade Bio, Inc. (NASDAQ:PALI) has completed patient enrollment in its dose optimization study of LB1148. The company expects to release topline data in Q3 2023. The study aims to generate pharmacokinetic and pharmacodynamic data across multiple doses in healthy adult volunteers and determine if a different dosing protocol might enhance the risk profile while providing efficacy for the development program.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 12:45 pm

CCCC

C4 Therapeutics announced that the FDA has cleared its investigational new drug application for CFT8919. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:39 pm

BTCUSD

ETHUSD

Two 17-year-olds from Hamilton, Ontario have been charged for stealing $4 million in cryptocurrency from a U.S. citizen by impersonating Coinbase Support. The cybercrime was uncovered in June 2023, leading to a joint investigation by Hamilton Police, the FBI, and the Secret Service Electronic Crimes Task Force. At the time of writing, Bitcoin (BTC) is trading at $30,818, down 0.70% in the last 24 hours.

Portfolio Pulse from Mehab Qureshi

July 05, 2023 | 12:38 pm

MP

MP Materials Corp (NYSE:MP) shares are trading higher following reports that China has imposed export restrictions on select rare earth metals, including gallium and germanium, used in semiconductor production, solar cells, and missiles. The restrictions, affecting over 35 other related metals and materials, will take effect from August 1. MP Materials, which produces specialty materials for advanced technologies, is currently expanding its manufacturing operations.

Portfolio Pulse from Adam Eckert

July 05, 2023 | 12:37 pm

GNPX

Genprex has been granted a Chinese patent for its REQORSA immunogene therapy in combination with PD-1 antibodies for cancer treatment. This expands the company's intellectual property rights and potentially opens up a new market for its product.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 12:36 pm